What is the recommended dose of digoxin (digitalis glycoside) for a patient with atrial fibrillation (a fib)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Digoxin Dosing in Atrial Fibrillation

For patients with atrial fibrillation, the recommended digoxin dosing is 0.125-0.25 mg daily for most adults with normal renal function, with lower doses (0.125 mg daily or every other day) for elderly patients over 70 years, those with impaired renal function, or low lean body mass. 1

Initial Dosing Strategy

Loading Dose (if needed for rapid rate control):

  • IV administration: 0.25-0.5 mg IV bolus initially
  • Can repeat 0.25 mg IV bolus up to maximum dose of 1.0 mg over 24 hours
  • Maximum loading dose: 8-12 mcg/kg given at 6-8 hour intervals 2

Maintenance Dose:

  • Standard maintenance dose: 0.125-0.25 mg daily 1, 3
  • Dose should be based on:
    • Age (lower doses for patients >70 years)
    • Lean body weight
    • Renal function
    • Concomitant medications 2, 1

Dosing Adjustments Based on Patient Factors

Renal Function:

  • For creatinine clearance <60 mL/min: Reduce dose to 0.125 mg daily 1
  • Patients with renal impairment have 2.6 times higher odds of experiencing toxic levels 1

Age:

  • Patients >70 years: 0.125 mg daily or every other day 1, 3

Body Weight:

  • For a 70 kg patient with normal renal function: 0.25 mg daily 1
  • Adjust based on lean body weight (not total body weight)

Monitoring and Target Levels

Serum Concentration:

  • Target therapeutic range: 0.5-0.9 ng/mL 1
  • Toxicity associated with levels >2.0 ng/mL 2, 3
  • Check levels 6-24 hours after administration 1

Heart Rate Targets:

  • Target heart rate: <80 bpm at rest, <110-120 bpm with exercise 1
  • Assess rate control within 24 hours of loading dose 4

Important Precautions

Contraindications:

  • Wolff-Parkinson-White (WPW) syndrome with AF
  • AV block greater than first degree or SA node dysfunction (without pacemaker)
  • Renal dysfunction (requires dose adjustment, not absolute contraindication) 2

Drug Interactions:

  • Reduce digoxin dose by 30-50% when used with amiodarone 2
  • Reduce digoxin dose by at least 50% when used with dronedarone 2
  • Monitor digoxin levels when used with: verapamil, clarithromycin, cyclosporine, erythromycin, flecainide, itraconazole, posaconazole, propafenone, voriconazole 2

Clinical Considerations

  • Digoxin is not effective for converting recent-onset AF to sinus rhythm 5
  • For patients with AF and rapid ventricular response, high doses of digoxin (>0.25 mg daily) for rate control are not recommended 3
  • When additional rate control is needed, consider adding a beta-blocker rather than increasing digoxin dose 3
  • A large retrospective study suggested increased mortality risk in patients treated with digoxin for newly diagnosed AF; use with caution 2

Signs of Toxicity to Monitor

  • Early signs: anorexia, nausea, vomiting, visual changes (seeing yellow halos)
  • Cardiac arrhythmias can occur with toxicity
  • Risk increases with hypokalemia, hypomagnesemia, or hypothyroidism 3

Remember that digoxin has a narrow therapeutic window, and careful dosing based on patient characteristics is essential to maximize efficacy while minimizing toxicity risk.

References

Guideline

Digoxin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Digoxin remains useful in the management of chronic heart failure.

The Medical clinics of North America, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.